--- SEARCH ---
WEATHER
CHINA
INTERNATIONAL
BUSINESS
CULTURE
GOVERNMENT
SCI-TECH
ENVIRONMENT
LIFE
PEOPLE
TRAVEL
WEEKLY REVIEW
Learning Chinese
Learn to Cook Chinese Dishes
Exchange Rates
Hotel Service


Hot Links
China Development Gateway
Chinese Embassies

Roche Aims to Grab Main Stake in China
Roche Chairman and CEO Franz B. Humer said China will become the company's largest market in the Asia-Pacific region within the next five to 10 years.

Although the China business now accounts for only 2 per cent of Roche's sales, it is growing very fast. China is now Roche's second biggest market in Asia-Pacific after Japan.

"In the long term I do not look at China only as a very important market of selling our drugs and diagnostics, but an extremely important scientific market. I am convinced that China has the potential to also develop a very strong research-based pharmaceutical and diagnostic industry," Humer told China Daily over the weekend.

Roche has already started its collaboration with Chinese institutions in the areas of genetics and genomics. A project to bring young Chinese scientists to Roche's laboratories is already under way.

"I am very pleased with the progress in that area and I think, over time, as these projects evolve and grow, we'll continue to invest in our R&D (research and development) in China," Humer said.

He said he would be surprised if in 10 years Roche does not have a large research base in China.

According to Humer, Roche has developed strategies over the last few years focusing on two high-tech pillars of its business - pharmaceuticals and diagnostics.

Within that context, Roche has disposed of a number of businesses two years ago, including those of fragrance and flavouring. In addition, sale of its bulk vitamin business to the Dutch company DSM, because "it no longer fits with Roche's overall health care strategy," is ongoing.

At the same time, Roche continues to strengthen the pharmaceutical and diagnostic businesses, not only through natural growth, but also through licensing and acquisition.

Roche is now the world's leader in oncology, diagnostics, transplant medicine, virology and in the treatment of obesity.

Humer expects that with the introduction of a number of new medicines in the coming months and years, Roche will continue to strengthen that position.

Roche plans to introduce its important breast cancer medicine Herceptin to the Chinese market next year. The medicine is based on the concept of the discovery of the human genome and is linked very closely to the identification of the specific genes in the disease.

Meanwhile, Roche will also introduce Pegasys - a once-weekly, pegylated form of interferon for the treatment of Hepatitis C - in China, the United States and Europe.

Humer said Roche is eyeing the Chinese market as many diseases common in the Western world are emerging in China, such as diabetes, cancer, high cholesterol and obesity.

Regarding the 10 million HIV sufferers in China by the year 2010 predicted by the United Nations, Humer said Roche wants to develop specific solutions with the Chinese authority to fight the problem.

"We will continue to work with international organizations to make sure that we can play our part in the treatment of AIDS, but our most important role is to make sure that we continue to research and develop new AIDS drugs."

"Certainly China can count on our continued support in that area," said Humer, who is in Shanghai to attend the annual International Business Leaders' Advisory Council for the Mayor of Shanghai and share his view on reforming Shanghai's health care system.

Roche, whose headquarters are in Basel, Switzerland, is one of the world's leading research-orientated health care groups. It now operates three joint ventures and three wholly owned companies in China, employing some 2,000 people. By the end of 2001, Roche's total investment in China topped US$203 million.

(China Daily November 5, 2002)

Roche Eyes Obesity Drug
Print This Page
|
Email This Page
About Us SiteMap Feedback
Copyright © China Internet Information Center. All Rights Reserved
E-mail: webmaster@china.org.cn Tel: 86-10-68326688
主站蜘蛛池模板: 人妻精品久久久久中文字幕一冢本 | 亚洲精品无码久久久久久久| 腿打开一下一会就不疼了| 国产特级毛片aaaaaa毛片| 911精品国产亚洲日本美国韩国| 好大好爽快点视频| 两个人看www免费视频| 日本三级在线观看中文字| 亚洲AV成人中文无码专区| 欧美成人18性| 亚洲精品乱码久久久久久| 男人和女人做爽爽视频| 出差被绝伦上司侵犯中文字幕| 色天天综合色天天碰| 国产又黄又刺激又爽视频黄| 色香蕉在线观看| 国产精品亚洲欧美一区麻豆| 8x8x华人永久免费视频| 在线播放无码后入内射少妇| www.99re99| 小草视频免费观看| 三级黄色片免费看| 房客(糙汉)何璐程曜坤| 久久96国产精品久久久| 日本在线观看成人小视频| 亚洲av无码片一区二区三区| 欧美成年黄网站色视频| 亚洲欧美校园春色| 波多野结衣bd| 亚洲精品无码专区在线 | 熟妇人妻不卡中文字幕| 伊人久久精品无码麻豆一区| 粗壮挺进人妻水蜜桃成熟| 内蒙大叔打桩机| 精品国产一区二区三区av片| 午夜性a一级毛片| 最新无码a∨在线观看| 十八在线观观看免费视频| 老少交欧美另类| 国产V综合V亚洲欧美久久| 久久99国产精品久久99|